Egan-Jones Analysis Finds CLO Issuance Subdued While Credit Quality Holds Steady

US CLO issuance fell to 98 deals totaling $40.5 billion in August, down 21% by deal count and 24% by volume from August 2025, as tight loan spreads and limited broadly syndicated loan supply compressed CLO equity returns. The slowdown does not appear to reflect weakening collateral: the ICE BofA US High Yield Index spread averaged 270bps, near a three-year low, while Egan-Jones-rated CLOs showed modestly improved weighted average rating scores and stable-to-lower CCC+ exposure. The report indicates weaker economics for new CLO formation but resilient credit quality in outstanding transactions.

Analysis

The key transmission is not current collateral impairment but a weakening marginal buyer for broadly syndicated loans. If CLO equity arbitrage remains uneconomic for another 1-3 months, loan demand should soften before reported defaults rise, widening new-issue loan concessions and reducing sponsor appetite for highly levered M&A. That would pressure fee pools tied to leveraged-finance underwriting, warehousing and syndication, while private-credit lenders gain relative pricing power on transactions that can no longer clear efficiently in the BSL market.

BAC is a low-beta expression of this theme: any hit to leveraged-finance fees is unlikely to move consolidated earnings materially, but a sustained slowdown would reinforce a broader capital-markets revenue headwind rather than a bank credit-loss thesis. The more exposed earnings risk sits with alternative managers with meaningful CLO origination/reset activity and banks carrying warehouse inventory; the latter can face mark-to-market and balance-sheet capacity pressure if loan spreads gap wider. Existing floating-rate CLO AAA holders may benefit from scarcity and stable collateral, but that support reverses if fewer new CLOs becomes evidence of deteriorating borrower funding access.

Consensus may over-read benign trustee metrics because they are lagging indicators and because weak CLO formation affects the price of incremental leverage, not necessarily the health of seasoned portfolios. The falsification point is straightforward: renewed CLO equity issuance alongside stable loan spreads would indicate a liability-cost/arbitrage normalization, removing the bearish financing signal. Conversely, a roughly 50bp widening in BSL spreads, rising loan discounts, or reduced LBO announcements over the next quarter would validate a more defensive credit stance.

Key Decisions for Investors

• Do not establish a directional BAC position on this signal alone; monitor 3Q/4Q leveraged-finance and investment-banking fee commentary, warehouse exposure, and loan-loss guidance. A meaningful guidance cut to capital-markets revenues—not stable CLO issuance alone—is the trigger for a tactical BAC underweight.
• Maintain a 1-3 month defensive tilt in leveraged-loan beta: reduce BKLN exposure or hedge it versus a long JAAA/CLOA allocation, expressing preference for senior CLO cash flows over direct loan-market exposure. Exit the relative trade if new-issue loan spreads tighten materially or CLO issuance reaccelerates for two consecutive months.
• Watch KKR, ARES, OWL and BX for a divergence between private-credit origination economics and CLO-management fee pressure. Favor selective private-credit exposure only after evidence that spreads on new direct loans are widening without a corresponding rise in non-accruals; absent that data, treat this as a watch item rather than a long recommendation.
• Set an alert for a 50bp widening in broadly syndicated loan spreads or a sustained increase in discounted loan prices. If triggered, consider a tactical long JAAA versus short BKLN; the payoff is asymmetric because senior CLO structures retain subordination while direct loan NAVs absorb spread and liquidity repricing first.